Prebiotic specialist Beneo-Orafti (Tienen, Belgium) has announced the results of a new study on overweight and obese subjects and its Orafti Synergy1 oligufructose-enriched inulin.
Prebiotic specialist Beneo-Orafti (Tienen, Belgium) has announced the results of a new study on overweight and obese subjects and its Orafti Synergy1 oligufructose-enriched inulin. Presented in Istanbul at the European Congress on Obesity, the study found that three weeks of a daily dose of Orafti Synergy1 resulted in reduced energy intake in 36 adult subjects.
In the double-blind crossover study, men and women were randomized to receive 6 g of Orafti Synergy1 twice daily (dissolved in a beverage at breakfast and lunch) or placebo for three weeks. Researchers conducting the study found that all subjects reduced energy intake with the inulin product by an average of 3.6%.
Beneo-Orafti says that this result complements previous research on animals and humans. In one human study, 16 g of Orafti Synergy1 daily resulted in 6% reduced energy intake in healthy subjects, reports of reduced hunger feelings, and increased levels of GLP-1 and PYY, two peptides involved in the pathway that signals satiety to the brain.
Microalgae extract supports metabolic health and bone mass during diet and exercise routine
April 11th 2024The extract from Microphyt, called PhaeOptim, was shown to complement weight management strategies that include diet and exercise by support bone mass, aerobic capacity, resting heart rate, and blood lipid profiles.